- Global Pharma News & Resources

11.3% CAGR of Pet Cancer Therapeutics Market Statistics, Regional, And Forecast to 2031

Pune, Maharashtra, India, September 19 2022 (Wiredrelease) Prudour Pvt. Ltd –:Global Pet Cancer Therapeutics Market: Introduction

Pet Cancer Therapeutics Market size registered a valuation of over USD 270.02 million in 2021. Driven by growing awareness among pet owners regarding pet diseases, the industry is poised to grow at a CAGR of about 11.3% from 2022 to 2030.

Pet cancer therapeutics are novel drug molecules that have high potential to reduce the impact of cancer. They provide comprehensive care for pets with minimal side effects. The goal of cancer therapies is to eradicate all cancerous cells in pets. The veterinarian will recommend a specific treatment plan, such as combination therapy, targeted therapy, or chemotherapy, depending on the type, stage, and nature the cancer.

Increased R&D in cancer management to increase market growth

The increasing number of research grants for anti-cancer treatments for veterinary cancer treatment will be a key factor in driving the growth of the global pet therapy market. The Blue Buffalo Foundation granted a US$1 million grant to Animal Cancer Foundation (ACF), in 2017 to support comparative oncology research. This was to examine the similarities between naturally occurring cancers in pets and people, and to find effective treatments in both.

To accelerate market growth, increase the incidence and remission rates for pet cancers.

The increasing incidence of cancer means that new therapies must be developed. These therapies have been proven to be extremely effective in treating cancers in pets. This will increase the market growth for pet cancer therapeutics during the forecast period. Fetch a Cure 2015 study found that dogs and cats are more likely than humans to develop cancer. In fact, dogs are 35% more likely develop skin cancer and 48% more likely to have breast cancer. Cats are 8 times more likely develop bone cancer. Animal Cancer Foundation published a study in 2017 that estimated 25% of dogs will develop cancer at some time in their lives. Market players will also benefit from an increase in relapsed cancer rates, and the availability of relapsed/refractory therapeutics that are integrated with veterinarian recommendations.

Identify the key factors that will drive your company’s growth. Request a brochure of this report here:

 [Sample reports can be used to check out our detailed reports and study material before purchasing] 

1. The updated 150+ page reports give an in-depth analysis and commentary on the COVID-19 virus pandemic. 

2. You can find out about industry data and interviews with experts to learn more about topics like regional impact analysis, global outlook, competitive landscape analysis, market size, share, and the size of regional markets. 

3. These reports are available in PDF format. You can view them on your computer or print them. 

4. PDF sample report provides additional information on Major Market Players including their Sales Volume, Business Strategy, Revenue Analysis and Revenue Analysis. This gives readers an advantage over other people. 

5. The Research report includes a detailed analysis of key factors that influence the market’s growth. 

6. Sample report also provides insight on major market players, their business strategies, and revenue analysis to give readers an edge over others.

Pet Cancer Therapeutics Market – Competitive Landscape 

Aratana Therapeutics Inc
AB Science
Boehringer Ingelheim International GmbH
Morphogenesis Inc
VetDC Inc
Karyopharm Therapeutics Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB

Competitive Benchmarking

Competitive benchmarking allows you to see how your competitors are doing and compare it to your company’s. professionals assist our stakeholders in keeping track of competitors, identifying improvement areas, increasing profits, and designing better go-to-market strategies.

Interested in Procure The Data? Inquire here at 

Pet Cancer Therapeutics Market Segmentation

Based on the type, the Pet Cancer Therapeutics market is segmented into 

Targeted Therapy
Combination Therapy

Based on the application, the Pet Cancer Therapeutics market is segmented into

Mast Cell Cancer
Squamous Cell Cancer

Market Breakup by Region: 

– North America (United States, Canada) 

– Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) 

– Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) 

– Latin America (Brazil, Mexico, Others) 

– The Middle East and Africa 

Market Report Coverage and Deliverables will help you to understand:

1. Company revenue shares | revenue (US$ Mn)

2. Upcoming Regional opportunities

3. Latest trends & Market dynamics

4. Competitive benchmarking

5. Key Financial Charts

Grab the full detailed report here:

Key Questions Answered in This Report: 

Q1. What is the market size of Pet Cancer Therapeutics? 

Q2. What are the elements of retail Pet Cancer Therapeutics? 

Q3. What are the key decision drivers for service buyers? 

Q4. How can we accelerate our bidding process? 

Q5. What is the potential of the Pet Cancer Therapeutics Market? 

Q6. Who are the prominent players in Pet Cancer Therapeutics Market? 

Q7. What are the different types of Pet Cancer Therapeutics market? 

Q8. What are the top strategies that companies adopt in Pet Cancer Therapeutics Market? 

Q9. What is the future of Pet Cancer Therapeutics? 

Trending Reports (Book Now with Save 25% [Single User], 38% [Multi-User], 45% [Corporate Users] + Covid-19 scenario+ Impact of Russia-Ukraine war):

Induction Motors Market Business Growing Strategies, Industry Segmentation and Forecast 2031

Covering Machine Market Strategies [+Sales Growth], Factors and Forecast 2031

Blue Glass IRCF Market Potentially Growing Significant Business Opportunities to 2031

Aerospace Helmet Mounted Display Market Segmentation, Operating Business Segments 2031

Augmented and Virtual Reality Eyeglass Market Globally Expected to Drive Growth [+Net Income] | 2022-2031

Get in Touch with Us :

Global Business Development Teams – (Powered By Prudour Pvt. Ltd.)

Send Email:

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351


Read Our Innovative Blogs @

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 19-Sep-2022